Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Goodwill & Intangibles (2023 - 2025)

Historic Goodwill & Intangibles for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $120000.0.

  • Tonix Pharmaceuticals Holding's Goodwill & Intangibles changed 0.0% to $120000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $120000.0 for FY2024, which is 9887.93% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Goodwill & Intangibles stood at $120000.0 for Q3 2025, which was down 0.0% from $120000.0 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Goodwill & Intangibles peaked at $11.2 million during Q2 2023, and registered a low of $120000.0 during Q2 2024.
  • Its 3-year average for Goodwill & Intangibles is $4.4 million, with a median of $120000.0 in 2024.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first plummeted by 9892.71% in 2024, then changed by 0.0% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Goodwill & Intangibles stood at $10.7 million in 2023, then crashed by 98.88% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025.
  • Its Goodwill & Intangibles was $120000.0 in Q3 2025, compared to $120000.0 in Q2 2025 and $120000.0 in Q1 2025.